Apidra SoloStar 100IU/ml – 3ml × 5 Prefilled Insulin Pens

Description

Apidra SoloStar contains Insulin Glulisine (100IU/ml), a rapid-acting insulin analog used to control high blood sugar in patients with type 1 and type 2 diabetes mellitus. It starts working quickly after injection, making it effective for managing post-meal blood sugar spikes. Each pack includes 5 prefilled SoloStar pens (3ml each) for convenient and precise dosing.

Ingredients

• Active Ingredient: Insulin Glulisine (100IU/ml)

• Inactive Ingredients: Trometamol, sodium chloride, polysorbate 20, hydrochloric acid/sodium hydroxide (for pH adjustment), and water for injection

Drug Class

• Antidiabetic – Rapid-acting Insulin Analog

Dosage Form

• Prefilled Insulin Injection Pens (3ml each × 5)

Uses

• Treatment of type 1 diabetes mellitus

• Treatment of type 2 diabetes mellitus when oral antidiabetics are not enough

• Rapid control of post-meal hyperglycemia

• Used as part of basal-bolus insulin therapy

Dosage

• Individualized based on blood glucose monitoring, diet, and physical activity

• Usually administered within 15 minutes before or immediately after meals

• Can be combined with long-acting or intermediate-acting insulin as part of therapy

• Must be prescribed and monitored by a healthcare professional

In Case of Overdose

• Symptoms: Severe hypoglycemia (sweating, tremors, dizziness, confusion, seizures, fainting)

• Management: Take oral glucose (sugar, juice, glucose tablets) if conscious. Severe cases may require IV glucose or glucagon injection in hospital.

Missed Dose

• If missed, check blood sugar immediately

• Take dose with next meal if possible

• Do not double dose – consult your doctor for guidance

• Always monitor glucose closely after a missed dose

How to Use

• For subcutaneous injection (under the skin) in abdomen, thigh, or upper arm

• Rotate injection sites to avoid skin thickening or lipodystrophy

• Do not inject into veins or muscles unless advised

• SoloStar pen is prefilled and ready-to-use; follow device instructions carefully

• Should only be used under medical guidance

When Not to Use

• Allergy to Insulin Glulisine or any ingredient of the formulation

• During episodes of hypoglycemia (low blood sugar)

• Should not be shared between patients (risk of cross-infection)

Side Effects

Common:

• Hypoglycemia (low blood sugar)

• Redness, itching, or swelling at injection site

• Weight gain

• Mild allergic reactions

Serious (seek immediate medical help):

• Severe allergic reactions (rash, swelling, difficulty breathing)

• Severe hypoglycemia (loss of consciousness, seizures)

• Low potassium levels (muscle weakness, irregular heartbeat)

Precautions & Warnings

• Regularly monitor blood sugar and HbA1c levels

• Use with caution in patients with kidney or liver disease

• Dose may need adjustment during illness, stress, or changes in diet/activity

• Avoid alcohol as it can increase risk of hypoglycemia

• Pregnant or breastfeeding women should use only under medical advice

Drug Interactions

• Oral antidiabetic drugs (increase hypoglycemia risk)

• Corticosteroids, diuretics, thyroid hormones (may raise blood sugar)

• Beta-blockers (may mask hypoglycemia symptoms)

• ACE inhibitors and salicylates (may enhance insulin effect)

Storage/Disposal

• Store unopened pens in refrigerator (2–8°C)

• Do not freeze

• Once in use, store at room temperature (below 30°C) for up to 28 days

• Keep away from heat, moisture, and direct sunlight

• Dispose of used pens and needles safely in sharps containers

Control Drug

• Yes – Prescription-only medicine

Quick Tips

• Always check the insulin label before injecting to avoid mix-ups

• Carry a source of sugar (glucose tablets/juice) for sudden low sugar episodes

• Do not skip meals after insulin injection

• Keep an insulin travel kit when traveling

• Never share your insulin pen with others